110 related articles for article (PubMed ID: 25933159)
1. A novel micelle-forming material used for preparing a theranostic vehicle exhibiting enhanced in vivo therapeutic efficacy.
Chen HP; Chen MH; Tung FI; Liu TY
J Med Chem; 2015 May; 58(9):3704-19. PubMed ID: 25933159
[TBL] [Abstract][Full Text] [Related]
2. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.
Hu J; Qian Y; Wang X; Liu T; Liu S
Langmuir; 2012 Jan; 28(4):2073-82. PubMed ID: 22047551
[TBL] [Abstract][Full Text] [Related]
3. A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation.
Chen HP; Tung FI; Chen MH; Liu TY
J Control Release; 2016 Mar; 226():182-92. PubMed ID: 26892750
[TBL] [Abstract][Full Text] [Related]
4. Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
Shen JM; Guan XM; Liu XY; Lan JF; Cheng T; Zhang HX
Bioconjug Chem; 2012 May; 23(5):1010-21. PubMed ID: 22486419
[TBL] [Abstract][Full Text] [Related]
5. A novel bubble-forming material for preparing hydrophobic-agent-loaded bubbles with theranostic functionality.
Yang PS; Tung FI; Chen HP; Liu TY; Lin YY
Acta Biomater; 2014 Aug; 10(8):3762-74. PubMed ID: 24830551
[TBL] [Abstract][Full Text] [Related]
6. A novel ultrasound-triggered drug vehicle with multimodal imaging functionality.
Liu TY; Wu MY; Lin MH; Yang FY
Acta Biomater; 2013 Mar; 9(3):5453-63. PubMed ID: 23201019
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
8. Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Liu C; Yuan J; Luo X; Chen M; Chen Z; Zhao Y; Li X
Mol Pharm; 2014 Nov; 11(11):4258-69. PubMed ID: 25238329
[TBL] [Abstract][Full Text] [Related]
9. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
11. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
[TBL] [Abstract][Full Text] [Related]
13. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery.
Qu D; Lin H; Zhang N; Xue J; Zhang C
Carbohydr Polym; 2013 Jan; 92(1):545-54. PubMed ID: 23218334
[TBL] [Abstract][Full Text] [Related]
17. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
18. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo.
Lee CM; Jang D; Kim J; Cheong SJ; Kim EM; Jeong MH; Kim SH; Kim DW; Lim ST; Sohn MH; Jeong YY; Jeong HJ
Bioconjug Chem; 2011 Feb; 22(2):186-92. PubMed ID: 21243999
[TBL] [Abstract][Full Text] [Related]
19. A pH-responsive chitosan-b-poly(p-dioxanone) nanocarrier: formation and efficient antitumor drug delivery.
Tang DL; Song F; Chen C; Wang XL; Wang YZ
Nanotechnology; 2013 Apr; 24(14):145101. PubMed ID: 23481178
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
